Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle

Journal of Neurology

Volumn 251, Issue 1, 2004, Pages 53-65

  Friedrich, Oliver ^a   Hund, Ernst ^a   Weber, Cornelia ^a   Hacke, Werner ^a   Fink, Rainer H A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Calcium regulation; Contractility; Critical illness myopathy; Membrane excitability; Skeletal muscle

Indexed keywords

VOLTAGE GATED CALCIUM CHANNEL;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; EXCITABILITY; HUMAN; MALE; MEMBRANE DEPOLARIZATION; MOUSE; MUSCLE FUNCTION; MYOPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SEPSIS; SERUM; SKELETAL MUSCLE;

ANIMALS; BLOOD PROTEINS; CALCIUM; CASE-CONTROL STUDIES; COMET ASSAY; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HUMANS; INTRACELLULAR SPACE; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; MUSCLE FIBERS, FAST-TWITCH; MUSCLE, SKELETAL; MUSCULAR DISEASES; PATCH-CLAMP TECHNIQUES; SARCOPLASMIC RETICULUM; SERUM; SODIUM CHANNELS; TIME FACTORS;

EID: 1142273145     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0272-z     Document Type: Article

References (57)

1. Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248(11):929-934
2. Hund E (2001) Critical illness polyneuropathy. Curr Opin Neurol 14:649-653
3. De Letter MACJ, van Doorn PA, Savelkoul HFJ, Laman JD, Schmitz PIM, Op de CouL AAW, Visser LH, Kros JM, Teepen JI, van der Meche FG (2000) Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 106:206-213
4. De Letter MACJ, Schmitz PIM, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29: 2281-2286
5. Lacomis D, Petrella JT, Giuliani MJ (1998) Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 21:6101-6617
6. Hund E, Grenzwürker H, Böhrer H, Jakob H, Thiele R, Hacke W (1997) Predominant involvement of motor fibers in patients with critical illness polyneuropathy. Br J Anaesth 78: 274-278
7. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A (1996) Critical illness myopathy and polyneuropathy. Lancet 347: 1579-1582
8. Latronico N, Rasulo FA, Recupero D, Beindorf A, Liberini P, Stefini R, Candiani A (1998) Acute quadriplegia with delayed onset and rapid recovery. J Neurosurg 88(4):769-762
9. Witt NJ, Zochodne DW, Bolton CF, Grand Maison F, Wells G, Young GB, Sibbald WJ (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99(1):176-184
10. Spitzer R, Giancarlo T, Maher L, Awerbuch G, Bowles A (1992) Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 15(6):682-686
11. Al-Lozi MT, Pestronk A, Yee WC, Flaris N (1995) Myopathy and paraproteinemia with serum IgM binding to a high-molecular-weight muscle fiber surface protein. Ann Neurol 37(1):41-46
12. Carpenter S, Massa R, Karpati G (1990) Depletion and reconstitution of thick myofilaments in steroid treated rat solei after denervation and reinnervation. J Neurol Sci 98(suppl):377-378
13. Carpenter S, Danon MJ (1991) Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14:1131-1139
14. Griffin D, Fairman N, Coursin D, Rawsthrone L, Grossman JE (1992) Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 102(2):510-514
15. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S (1994) Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 17(3):285-289
16. Ruff RL (1998) Why do ICU patients become paralyzed? [editorial, comment]. Ann Neurol 43:154-155
17. Hudson LD, Lee CM (2003). Neuromuscular sequelae of critical illness. N Engl J Med 348(8):745-747
18. Hund E (1999) Myopathies in the critically ill. Crit Care Med 27:2544-2547
19. Goldberg AL, Mitch WE (1996) Mechanisms of muscle wasting. N Engl J Med 335:1897-1905
20. Cooney RN, Kimball SR, Vary TC (1997) Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7(1):1-16
21. Lacomis D (2002) Critical Illness Myopathy. Curr Rheumatol Rep 4(5): 403-408
22. Engel AG, Showalter CJ (1997) Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 20:316-322
23. Massa R, Carpenter S, Holland P, Karpati G (1992) Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 15: 1290-1298
24. Lehrer RI, Ganz T (1999) Antimicrobial peptides in mammalian and insect host defense. Curr Opin Immunol 11: 23-27
25. Giulian D, Corpuz M, Chapman S, Mansouri M, Robertson C (1993) Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 36:681-693
26. Deconinck N, van Parijs V, Beckers-Bleuks G, van den Bergh P (1998) Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 8:186-192
27. Rich MM, Bird SJ, Raps EC, McCluskey IF, Teener JW (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20(6):665-673
28. Pinter MJ, Rich MM (2001) Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 50(1):26-33
29. Rich MM, Pinter MJ, Kraner SD, Barchi RL (1998) Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 43(2): 171-179
30. Pinter MJ, Rich MM (2003) Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 547(2):555-566
31. Verheul GAM, de Jongh-Leuvenink J, Op de Coul AAW, van Landeghem AAJ, van Puyenbroek MJE (1994) Tumor necrosis factor and interleukin-6 in critical illness polyneuro(myo)pathy. Clin Neurol Neurosurg 96(4):300-304
32. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
33. Friedrich O, Ehmer Th, Fink RHA (1999) Calcium currents during contraction and shortening in enzymatically isolated murine skeletal muscle fibres. J Physiol 517.3:757-770
34. 2+ depletion in the transverse tubular system of mammalian muscle. Biophys J 80: 2046-2055
35. Friedrich O, Kress KR, Ludwig H, Fink RHA (2002) Membrane ion conductances of mammalian skeletal muscle in the post-decompression state after high-pressure treatment. J Membr Biol 188:11-22
36. Pappone PA (1980) Voltage-Clamp experiments in normal and denervated mammalian skeletal muscle fibres. J Physiol 306:377-410
37. Almers W, Stanfield PR, Stühmer W (1983) Lateral distribution of sodium and potassium channels in frog skeletal muscle: measurements with a patch-clamp technique. J Physiol 336: 261-284
38. Almers W, Roberts WM, Ruff RL (1984) Voltage clamp of rat and human skeletal muscle: measurements with an improved loose-patch technique. J Physiol 347:751-768
39. Anson BD, Roberts WM (2001) Sodium channel distribution on uninnervated and innervated embryonic skeletal myotubes. J Neurobiol 48(1): 42-57
40. Caldwell JH, Campbell DT, Beam KG (1986) Na channel distribution in vertebrate skeletal muscle. J Gen Physiol 87(6):907-932
41. Adrian RH, Chandler WK, Hodgkin AL (1970) Voltage clamp experiments in striated muscle fibres. J Physiol 208: 607-644
42. 2+-transients of murine skeletal muscle fibres. Pflügers Arch-Eur J Physiol 432: 717-726
43. 2+ release from the sarcoplasmic reticulum of mammalian skeletal muscle. Anesthesiol 93: 832-836
44. Benardeau A, Hatem SN, Rucker MC, Tessier S, Dinanian S, Samuel JL, Coraboeuf E, Mercadier JJ (1997) Primary culture of human atrial myocytes is associated with the appearance of structural and functional characteristics of immature myocardium. J Mol Cell Cardiol 29(5): 1307-1320
45. Kang JX, Xiao YF, Leaf A (1995) Free, long chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Nat Acad Sci USA 92(2): 3997-4001
46. Losavio A, Muchnik S, Sica RE, Panizza M (1989) Changes in tetrodotoxin-resistant action potentials after passive transfer of myasthenia gravis patient sera. J Neurol Sci 91(3):345-351
47. Garcia S, Nascimento JH, Bonfa E, Levy R, Oliveira SF, Tavares, De Carvalho AC (1994) Cellular mechanisms of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest 93(2):718-724
48. Losavio A, Muchnik S, Panizza M, Sica RE, Jauregui WO (1989) Effect of passive transfer of myasthenic serum on mechanical, electrical and neuromuscular transmission properties of mouse skeletal muscle. Medicina 49(1):7-13
49. Saum WR, McGee R, Love J (1981) Alteration of the action potential of tissue cultured neuronal cells by grown in the presence of a polyunsaturated fatty acid. Cell Mol Neurobiol 1(3): 319-324
50. Wurz A, Brinkmeier H, Wollinsky KH, Mehrkens HH, Kornhuber HH, Rüdel R (1995) Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels. Muscle Nerve 18(7):772-781
51. Weber F, Rüdel R, Aulkemeyer P, Brinkmeier H (2000) Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve 23(9):1414-1420
52. Besarab A, DeGuzman A, Swanson JW (1981) Effect of albumin and free calcium concentrations on calcium binding in vitro. J Clin Pathol 34(12): 1361-1367
53. Hund E, Herkert M, Becker CM, Hacke W (1996) A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy (abstr.). Ann Neurol 40:539
54. Druschky A, Herkert M, Radespiel-Troger M, Druschky K, Hund E, Becker CM, Hilz MJ, Erbguth F, Neundorfer B (2001) Critical Illness Polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 27(4): 686-693
55. Brinkmeier H, Aulkemeyer P, Wollinsky KH, Rüdel R (2000) An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat Med 6:808-811
56. + channel by protein kinase C. Proc Natl Acad Sci USA 92:12003-12007
57. Bennett E, Urcan MS, Tinkle SS, Koszowski AG, Levinson SR (1997) Contribution of sialic acid to the voltage dependence of sodium channel gating. A possible electrostatic mechanism. J Gen Physiol 109:327-343